A7168112
Ruxolitinib phosphate salt , 98% , 1092939-17-7
CAS NO.：1092939-17-7
Empirical Formula: C17H21N6O4P
Molecular Weight: 404.37
MDL number: MFCD18452860
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB191.20 | In Stock |
|
| 25mg | RMB431.20 | In Stock |
|
| 50mg | RMB775.20 | In Stock |
|
| 100MG | RMB1359.20 | In Stock |
|
| 250mg | RMB3063.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 186-190°C |
| storage temp. | Refrigerator |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | White to Off-White |
| InChI | InChI=1/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/s3 |
| InChIKey | JFMWPOCYMYGEDM-AVAJOTNLNA-N |
| SMILES | P(O)(O)(O)=O.[C@@H](C1CCCC1)(N1N=CC(C2N=CN=C3NC=CC=23)=C1)CC#N |&1:5,r| |
Description and Uses
The phosphate salt of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
Safety
| Symbol(GHS) |   GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301-H361-H373 |
| Precautionary statements | P260-P280-P308+P313 |
| HS Code | 29331990 |
